Boston Scientific settles Guidant suits for $195 million
679156
Boston Scientific Corp.  said on Friday it will pay $195 million to settle numerous legal claims related to the recall of implantable heart defibrillators made by Guidant Corp., which it acquired last year.
494872
Boston Scientific Corp. , the state's largest life-science company, lost $3.6 billion last year thanks to its expensive acquisition of heart-device maker Guidant Corp. , and executives said yesterday they weren't certain when sales of its most important products would begin to recover from their slump.
650293
Embattled hospital chain Tenet Healthcare will pay $395 million to settle lawsuits with former patients who accused one of its medical centers of performing unnecessary heart surgeries, the company announced Tuesday.
570337
Cardiovascular device maker Guidant Corp. (GDT.N: Quote, Profile, Research) said on Wednesday US regulators cleared the use of its implantable heart failure therapies for a wider group of patients.
653551
Pfizer Inc., the world&#39;s largest drugmaker, agreed to pay $430 million to resolve personal-injury claims against a subsidiary that sold products containing asbestos in the 1970s.
684623
A hospital attorney says the deal shows both sides saw strengths and flaws in their cases. Tenet Healthcare Corp. announced Thursday that it will pay $31 million to settle more than 100 individual patient
64992
Medarex Inc., a Princeton, NJ, biotechnology company, could receive up to $510 million under a global collaboration deal it signed with New York-based Pfizer Inc.
253054
A jury in Texas has ruled that Boston Scientificâs drug-coated stents infringe a 1997 patent issued to a radiologist in Princeton, N.J., and has awarded the inventor $431 million in damages, Boston Scientific said Tuesday. The suit by the patent holder, Dr. Bruce N. Saffran, did not seek to halt sales of the stents.
646222
The anticipated merger of Guidant Corp. and Johnson &amp; Johnson could give an unintended boost to Boston Scientific Corp. if Guidant's drug-coated stent launch is delayed, said analysts looking at the implications of a potential deal.
21679
The anticipated merger of Guidant Corp.  and Johnson & Johnson could give an unintended boost to Boston  Scientific Corp. if Guidant's drug-coated stent launch is  delayed, said analysts looking at the implications of a  potential deal.
243896
Boston Scientific Corp. has reserved another $101 million to defend itself against lawsuits over defibrillators made by Guidant Corp., the heart-device maker it acquired for $27 billion last year. The Natick medical-device company has set aside $485 million to pay for legal costs related to Guidant, it said in a filing this week, up from $384 million in ...
339733
DuPont agreed to a settlement Thursday that could be worth more than $340 million to resolve a class action lawsuit alleging the chemical giant contaminated a West Virginia community's water supply with a key ingredient used in its Teflon products.
476254
GlaxoSmithKline Plc, Europe&#39;s largest drugmaker, said it settled a lawsuit filed by New York Attorney General Eliot Spitzer, who accused the drugmaker last June of withholding safety data on the antidepressant Paxil.
238678
Pfizer, the world&#39;s largest drug maker, agreed Friday to pay $430 million to resolve personal-injury claims against a subsidiary that sold products containing asbestos in the 1970s.
604894
Hewlett-Packard Co., a leading maker of personal computers and printers, has agreed to pay &#36;141 million to settle patent disputes with software maker Intergraph Corp., both companies announced Friday.
521877
INDIANAPOLIS - New Jersey-based health care products giant Johnson &amp; Johnson is buying Guidant Corp., one of the world&#39;s top makers of cardiac devices, for about $25.4 billion in cash and stock.
356908
DENVER Indianapolis-based Guidant Corporation says it has won the right to a new trial in its lawsuit seeking up to 140 (m) million dollars in damages from another maker of implantable defibrillators.